Overview

Dose Response Study of Patients With Erythematous Rosacea

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the dose-response relationship (effect) of four concentrations of V-101 Cream in patients with erythematous(redness) rosacea.
Phase:
Phase 2
Details
Lead Sponsor:
Vicept Therapeutics, Inc.
Collaborator:
Accenture